Ads
related to: Buy Inhalers Copd- Type 2 COPD
Type 2 Inflammation Might Be
The Underlying Cause Of COPD
- Recognize
Read About COPD Symptoms &
See How It Impacts Patients
- Type 2 COPD
Search results
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
Zacks via Yahoo Finance· 7 days agoGSK plc (GSK) plans to lower the prices of its entire inhaled respiratory products to $35 per month...
Honeywell (HON), Recipharm Unite to Develop Near-Zero GWP pMDIs
Zacks via Yahoo Finance· 7 months agoHoneywell International Inc. HON recently partnered with global contract development and...
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars
Investor's Business Daily· 1 year agoSanofi and Regeneron Pharmaceuticals' asthma drug Dupixent succeeded in a final-phase study of...
These 2022 Winning Stocks Can Keep Soaring in 2023, Say Analysts
TipRanks via Yahoo Finance· 1 year agoSeesaw trading and mixed messages – that’s been the market’s pattern for the past few weeks, and...
Climate change among factors that can worsen symptoms for asthma sufferers
The Columbus Dispatch via Yahoo News· 2 years agoTwenty-two years ago, Richard Tovar had his first asthma attack. He remembered that day in 2000...
Theravance's (TBPH) Q2 Earnings Beat, Focus on Pipeline
Zacks via Yahoo Finance· 2 years agoTheravance Biopharma, Inc. TBPH reported adjusted loss (excluding restructuring and related...
GSK Gears Up to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 11 months agoGSK plc. GSK will report first-quarter 2023 results on Apr 26, before the opening bell. In the last...
GSK Gears Up for Q4 Earnings: Will It Surpass Estimates?
Zacks via Yahoo Finance· 2 months agoWe expect GSK plc. GSK to beat expectations when it reports fourth-quarter and full-year 2023...
The worst day of the year for hay fever is here: Why is it so bad at the moment?
Yahoo Life UK· 2 years agoBrace yourself for a bad bout of hay fever today. (Getty Images) Getty Images Prepare for some heavy...
Theravance (TBPH) Q3 Loss Narrower Than Expected, Sales Miss
Zacks via Yahoo Finance· 1 year agoTheravance Biopharma, Inc. TBPH reported third-quarter 2022 net loss of 21 cents per share, narrower...
Ads
related to: Buy Inhalers Copd